Screener
Neurocrine Biosciences NBIX Preferred Stock Par Value Per Share
Preferred Stock Par Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The source filing: Neurocrine Biosciences’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000914475-26-000026
| (in millions, except per share data) | March 31,2026 | December 31,2025 |
|---|---|---|
| Other noncurrent liabilities | 260.9 | 219.7 |
| Total liabilities | 1,498.8 | 1,378.4 |
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value; 5.0 shares authorized; no shares issued and outstanding | — | — |
| Common stock, $0.001 par value; 220.0 shares authorized; 100.6 and 100.1 shares issued and outstanding, respectively | 0.1 | 0.1 |
| Additional paid-in capital | 2,817.3 | 2,792.2 |
| Accumulated other comprehensive income | 0.4 | 13.1 |
| Retained earnings | 589.6 | 447.7 |
Item 1. Financial Statements
FAQ
- What is Neurocrine Biosciences's preferred stock par value per share?
- Neurocrine Biosciences (NBIX) reported preferred stock par value per share of $0.00 in Q1 2026.
- How has Neurocrine Biosciences's preferred stock par value per share changed year-over-year?
- Neurocrine Biosciences's preferred stock par value per share decreased by 0.0% year-over-year, from $0.00 to $0.00.
- What is the long-term trend for Neurocrine Biosciences's preferred stock par value per share?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's preferred stock par value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0.00 to $0.00.
- What does preferred stock par value per share mean?
- The par value per share of preferred stock is a nominal value assigned to preferred shares for accounting and legal purposes. It does not reflect the market value or the liquidation preference of the stock. It is primarily a regulatory and historical accounting figure.
Ask your AI about Neurocrine Biosciences's preferred stock par value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude